Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma 3Myelodysplastic Syndromes 2Unspecified Childhood Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Recurrence 1Pancreatic Neoplasms 1Ototoxicity 1Neurotoxicity Syndromes 1Neoplasm, Residual 1Neoplasm Metastasis 1Myasthenia Gravis 1Multiple Myeloma 1Microbiota 1Metabolic Diseases 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Immunologic Deficiency Syndromes 1Immunoglobulin Light-chain Amyloidosis 1Hormone Refractory Prostate Cancer 1Fatigue 1Central Nervous System Neoplasms 1Breast Cancer Organoids 1Breast Cancer Metastatic 1Brain Neoplasms 1

Interventions

etoposide phosphate 1Mass Spectrometry 1Genetic Testing 1Gene Expression Profiling 1Cyclophosphamide 1Carboplatin 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Unspecified Childhood Solid Tumor, Protocol Specific × Cyclophosphamide × Clear all
NCT00897871 2013-08-12

Evaluating the Side Effects and How Well Anticancer Drugs Work in Very Young Patients With Cancer

National Cancer Institute (NCI)

Unknown
60 enrolled
Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡